top of page
News, Events and Updates
Search
Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wed., November 24, 2021
Nov 17, 2021
Building Global Momentum for Interventions in Alzheimer's Disease - a Lausanne VIII Workshop Panel
Nov 10, 2021
Anavex Life Sciences to Present at the Dawson James Securities 6th Annual Conference
Oct 15, 2021
Data Review by the Independent DSMB reported for Phase 2b/3 Trial of ANAVEX®2-73 for AD
Oct 13, 2021
Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market®
Sep 27, 2021
Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access
Sep 27, 2021
Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference
Sep 20, 2021
Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Sep 9, 2021
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 in FragileX Syndrome
Aug 26, 2021
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result
Aug 12, 2021
Anavex Life Sciences to Announce Fiscal 2021 3rd Quarter Financial Results on Thurs., Aug. 12, 2021
Aug 5, 2021
9
10
11
12
13
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
